Advanced search
Publication Cover
Autoimmunity Volume 36, 2003 - Issue 5
Submit an article Journal homepage
17
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Exon-1 Polymorphism of ctla-4 Gene in Iranian Patients with Graves' Disease

T. Kalantari Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
,
H. Mostafavi Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
,
A.M. Pezeshki Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
,
S. Farjadian Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
,
M. Doroudchi Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
,
F. Yeganeh Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
&
A. Ghaderi Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, IranCorrespondence[email protected]
 show all
Pages 313-316 | Received 03 Apr 2003, Accepted 02 Jun 2003, Published online: 07 Jul 2009

  • Yanagawa, T., Mangklabruks, A., Chang, Y.B., Okamoto, Y, Fisfalen, ME., Curran, PG. and DeGroot, L.J. (1993) "Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population", J. Clin. Endocrinol. Metab. 76, 1569–1574.
  • Vaidya, B., Imrie, H., Perros, P., Young, E.T., Kelly, WE, Can, D., et al. (1999) "The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus", Hum. Mol. Genet. 8, 1195–1199.
  • Walunas, Ti., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., et al. (1994) "CTLA-4 can function as a negative regulator of T cell activation", Immunity 1, 405–413.
  • Krummel, M.F. and Allison, J.P. (1996) "CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells", J. Exp. Med. 183, 2533–2540.
  • Brunner, MC., Chambers, CA., Chan, F.K., Hanke, J., Winoto, A. and Allison, J.P. (1999) "CTLA-4-Mediated inhibition of early events of T cell proliferation", J. ImmunoL 162, 5813–5820.
  • Thornton, A.M. and Shevach, E.M. (1998) "CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production", J. Exp. Med. 188, 287–296.
  • Takahashi, T., Kuniyasu, Y, Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., et al. (1998) "Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state", Int. ImmunoL 10, 1969–1980.
  • Levings, M.K., Sangregorio, R. and Roncarolo, M.G. (2001) "Human cd25(+)cd4(+ ) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function", J. Exp. Med. 193, 1295–1302.
  • Takahashi, T., Tagami, T., Yamazald, S., Uede, T., Shimizu, J., Sakaguchi, N., et al. (2000) "Immunologic self-tolerance maintained by CD25(+)CD4(+ ) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4", J. Exp. Med. 192, 303–310.
  • Ligers, A., Teleshova, N., Masterman, T., Huang, W.X. and Hillert, J. (2001) "CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms", Genes Immun. 2, 145–152.
  • Heward, J.M., Allahabadia, A., Armitage, M., Hattersley, A., Dodson, P.M., Macleod, K. et al. (1999) "The development of Graves' disease and the CTLA-4 gene on chromosome 2q33", J. Clin. Endocrinol. Metab. 84, 2398–2401.
  • Kinjo, Y, Takasu, N., Komiya, I., Tomoyose, T., Takara, M., Kouki, T., et al. (2002) "Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene", J. Clin. Endocrinol. Metab. 87, 2593–2596.
  • Yung, E., Cheng, P.S., Fok, T.F. and Wong, G.W. (2002) "CTLA-4 gene A—G polymorphism and childhood Graves' disease", Clin. Endocrinol. 56, 649–653.
  • Park, Y.J., Chung, H.K., Park, D.J., Kim, W.B., Kim, S.W., Koh, J.J. and Cho, B.Y. (2000) "Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans", Thyroid 10, 453–459.
  • Hadj Kacem, H., Bellassoued, M., Bougacha-Elleuch, N., Abid, M. and Ayadi, H. (2001) "CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease", Clin. Immunol. 101, 361–365.
  • Chen, Q.Y., Nadell, D., Zhang, X.Y., Kukreja, A., Huang, Y.J., Wise, J., et al. (2000) "The human leukocyte antigen HLA DRB3*020/ DQA1*0501 haplotype is associated with Graves' disease in African Americans", J. Clin. Endocrinol. Metab. 85, 1545–1549.
  • Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) "A simple salting out procedure for extracting DNA from human nucleated cells", Nucleic Acids Res. 16, 1215.
  • Donner, H., Braun, J., Seidl, C., Rau, H., Finke, R., Ventz, M., et al. (1997) "Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease", J. Clin. Endocrinol. Metab. 82, 4130–4132.
  • Bourn, D., Carter, S.A., Mason, S., Gareth, D., Evans, R. and Strachan, T. (1994) "Germline mutations in neurofibromatosis type 2 tumor suppressor gene", Hum. MoL Genet. 3, 813–816.
  • Donner, H., Rau, H., Walfish, PG., Braun, J., Siegmund, T., Finke, R., et al. (1997) "CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus", J. Clin. Endocrinol. Metab. 82, 143–146.
  • Yanagawa, T., Taniyama, M., Enomoto, S., Gomi, K., Maruyama, H., Ban, Y. and Saruta, T. (1997) "CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese", Thyroid 7, 843–846.
  • Bachmann, M.F., Waterhouse, P., Speiser, D.E., McKall-Faienza, K., Mak, T.W. and Ohashi, P.S. (1998) "Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells", J. ImmunoL 160, 95–100.
  • Kouki, T., Sawai, Y, Gardine, CA., Fisfalen, ME., Alegre, M.L. and DeGroot, L.J. (2000) "CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease", J. ImmunoL 165, 6606–6611.
  • Maurer, M., Loserth, S., Kolb-Maurer, A., Ponath, A., Wiese, S., Kruse, N. and Rieckmann, P. (2002) "A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA-4) gene (exon 1 +49) alters T-cell activation", Immunogenetics 54, 1–8.
  • Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M.C. and Polychronakos, C. (2002) "A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele", J. Biol. Chem. 277, 46478–46486.
  • Kocjan, T., Wraber, B., Repnik, U. and Hojker, S. (2000) "Changes in Thl/Th2 cytokine balance in Graves' disease", Pflugers Arch. 440((5 Suppl)), R94—R95.
  • Tomer, Y, Greenberg, D.A., Barbesino, G., Concepcion, E. and Davies, T.F. (2001) "CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production", J. Clin. Endocrinol. Metab. 86, 1687–1693.
  • Zaletel, K., Krhin, B., Gaberscek, S., Pirnat, E. and Hojker, S. (2002) "The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease", Thyroid 12, 373–376.
  • Schweitzer, AN. and Sharpe, A.H. (1998) "Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th 1 cytokine production", J. ImmunoL 161, 2762–2771.
  • Rulifson, LC., Sperling, Al., Fields, P.E., Fitch, F.W. and Bluestone, J.A. (1997) "CD28 costimulation promotes the production of Th2 cytokines", J. ImmunoL 158, 658–665.
  • Allahabadia, A., Heward, J.M., Nithiyananthan, R., Gibson, S.M., Reuser, T.T., Dodson, P.M., et al. (2001) "MHC class 11 region, CTLA-4 gene and ophthalmopathy in patients with Graves' disease", Lancet 358, 984–985.
  • Villanueva, R., Inzerillo, AM., Tomer, Y, Barbesino, G., Meltzer, M., Concepcion, ES., et al. (2000) "Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology", Thyroid 10, 791–798.
  • Bednarczuk, T., Hiromatsu, Y., Fukutani, T., Jazdzewski, K., Miskiewicz, P., Osikowska, M. and Nauman, J. (2003) "Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmo-pathy in European and Japanese populations", Eur. J. Endocrinol. 148, 13–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.